China Pharma Holdings, Inc.
CPHI
$1.43
$0.0151.06%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.72% | 0.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.72% | 0.20% | |||
| Cost of Revenue | -12.54% | -1.72% | |||
| Gross Profit | 36.08% | 15.26% | |||
| SG&A Expenses | -8.23% | -42.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.40% | -18.67% | |||
| Operating Income | 33.90% | 36.57% | |||
| Income Before Tax | 32.74% | 35.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.74% | 35.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.74% | 35.84% | |||
| EBIT | 33.90% | 36.57% | |||
| EBITDA | 57.93% | 42.61% | |||
| EPS Basic | 32.72% | 54.62% | |||
| Normalized Basic EPS | 32.76% | 54.63% | |||
| EPS Diluted | 32.72% | 54.62% | |||
| Normalized Diluted EPS | 32.76% | 54.63% | |||
| Average Basic Shares Outstanding | 0.00% | 41.36% | |||
| Average Diluted Shares Outstanding | 0.00% | 41.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||